TRENTON, N.J.--(BUSINESS WIRE)--BioNJ has announced its inaugural Patient Advocacy Summit, scheduled for Friday, November 4 at Celgene Corporation, Summit, NJ. The Summit will bring together New Jersey’s Patient Advocacy community with industry and government for a conference intended to Educate, Engage and Empower Patients and Patient Advocates on how they can impact the advancement of therapies and cures. Participants will learn effective ways to work with biopharmaceutical companies during the drug discovery process and have their voice heard to become more successful advocates.
